HEADER    COMPLEX (MHC I/PEPTIDE/CD8)             21-MAY-97   1AKJ
TITLE     COMPLEX OF THE HUMAN MHC CLASS I GLYCOPROTEIN HLA-A2 AND
TITLE    2 THE T CELL CORECEPTOR CD8
COMPND    MOL_ID: 1;
COMPND   2 MOLECULE: MHC CLASS I HISTOCOMPATIBILITY ANTIGEN;
COMPND   3 CHAIN: A, B;
COMPND   4 FRAGMENT: EXTRACELLULAR DOMAIN;
COMPND   5 SYNONYM: HLA-A2, HLA-A*0201;
COMPND   6 ENGINEERED: YES;
COMPND   7 BIOLOGICAL_UNIT: DIMER OF ALPHA CHAIN (CHAIN A) AND A BETA
COMPND   8 CHAIN OF BETA-2-MICROGLOBULIN (CHAIN B);
COMPND   9 MOL_ID: 2;
COMPND  10 MOLECULE: HIV REVERSE TRANSCRIPTASE EPITOPE;
COMPND  11 CHAIN: C;
COMPND  12 FRAGMENT: PEPTIDE, RESIDUES 309 - 317;
COMPND  13 ENGINEERED: YES;
COMPND  14 MOL_ID: 3;
COMPND  15 MOLECULE: T-CELL CORECEPTOR CD8;
COMPND;
COMPND  17 FRAGMENT: EXTRACELLULAR IGSF DOMAIN, RESIDUES 1 - 120,
COMPND  18 ALPHA CHAIN;
COMPND  19 ENGINEERED: YES;
COMPND  20 BIOLOGICAL_UNIT: ALPHA-ALPHA HOMODIMER
SOURCE    MOL_ID: 1;
SOURCE   2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE   3 ORGANISM_COMMON: HUMAN;
SOURCE   4 EXPRESSION_SYSTEM: ESCHERICHIA COLI;
SOURCE   5 EXPRESSION_SYSTEM_STRAIN: BL21 (DE3) PLYSS;
SOURCE   6 EXPRESSION_SYSTEM_VECTOR: PET23D;
SOURCE   7 EXPRESSION_SYSTEM_PLASMID: BJ075;
SOURCE   8 MOL_ID: 2;
SOURCE   9 SYNTHETIC: YES;
SOURCE  10 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS;
SOURCE  11 MOL_ID: 3;
SOURCE  12 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE  13 ORGANISM_COMMON: HUMAN;
SOURCE  14 EXPRESSION_SYSTEM: ESCHERICHIA COLI;
SOURCE  15 EXPRESSION_SYSTEM_STRAIN: BL21 (DE3) PLYSS;
SOURCE  16 EXPRESSION_SYSTEM_VECTOR: PGMT7;
SOURCE  17 EXPRESSION_SYSTEM_PLASMID: BJ112
KEYWDS    T-CELL, GLYCOPROTEIN, SIGNAL, COMPLEX, IMMUNOLOGY,
KEYWDS   2 COMPLEX (MHC I/PEPTIDE/CD8)
EXPDTA    X-RAY DIFFRACTION
AUTHOR    J.TORMO,D.I.STUART,E.Y.JONES
REVDAT   1   17-SEP-97 1AKJ    0
JRNL        AUTH   G.F.GAO,J.TORMO,U.C.GERTH,J.R.WYER,A.J.MCMICHAEL,
JRNL        AUTH 2 D.I.STUART,J.I.BELL,E.Y.JONES,B.K.JAKOBSEN
JRNL        TITL   CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN HUMAN
JRNL        TITL 2 CD8ALPHA(ALPHA) AND HLA-A2
JRNL        REF    NATURE                        V. 387   630 1997
JRNL        REFN   ASTM NATUAS  UK ISSN 0028-0836                 0006
REMARK   1
REMARK   2
REMARK   2 RESOLUTION. 2.65 ANGSTROMS.
REMARK   3
REMARK   3 REFINEMENT.
REMARK   3   PROGRAM     : X-PLOR 3.851
REMARK   3   AUTHORS     : BRUNGER
REMARK   3
REMARK   3  DATA USED IN REFINEMENT.
REMARK   3   RESOLUTION RANGE HIGH (ANGSTROMS) : 2.65
REMARK   3   RESOLUTION RANGE LOW  (ANGSTROMS) : 15.00
REMARK   3   DATA CUTOFF            (SIGMA(F)) : 0.0
REMARK   3   DATA CUTOFF HIGH         (ABS(F)) : 10000000.00
REMARK   3   DATA CUTOFF LOW          (ABS(F)) : 0.001
REMARK   3   COMPLETENESS (WORKING+TEST)   (%) : 96.7
REMARK   3   NUMBER OF REFLECTIONS             : 21207
REMARK   3
REMARK   3  FIT TO DATA USED IN REFINEMENT.
REMARK   3   CROSS-VALIDATION METHOD          : THROUGHOUT
REMARK   3   FREE R VALUE TEST SET SELECTION  : RANDOM
REMARK   3   R VALUE            (WORKING SET) : 0.206
REMARK   3   FREE R VALUE                     : 0.276
REMARK   3   FREE R VALUE TEST SET SIZE   (%) : 7.9
REMARK   3   FREE R VALUE TEST SET COUNT      : 1666
REMARK   3   ESTIMATED ERROR OF FREE R VALUE  : 0.007
REMARK   3
REMARK   3  FIT IN THE HIGHEST RESOLUTION BIN.
REMARK   3   TOTAL NUMBER OF BINS USED           : 6
REMARK   3   BIN RESOLUTION RANGE HIGH       (A) : 2.65
REMARK   3   BIN RESOLUTION RANGE LOW        (A) : 2.82
REMARK   3   BIN COMPLETENESS (WORKING+TEST) (%) : 95.6
REMARK   3   REFLECTIONS IN BIN    (WORKING SET) : 3143
REMARK   3   BIN R VALUE           (WORKING SET) : 0.304
REMARK   3   BIN FREE R VALUE                    : 0.358
REMARK   3   BIN FREE R VALUE TEST SET SIZE  (%) : 8.5
REMARK   3   BIN FREE R VALUE TEST SET COUNT     : 293
REMARK   3   ESTIMATED ERROR OF BIN FREE R VALUE : 0.021
REMARK   3
REMARK   3  NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK   3   PROTEIN ATOMS            : 4959
REMARK   3   NUCLEIC ACID ATOMS       : NULL
REMARK   3   HETEROGEN ATOMS          : NULL
REMARK   3   SOLVENT ATOMS            : 108
REMARK   3
REMARK   3  B VALUES.
REMARK   3   FROM WILSON PLOT           (A**2) : 47.2
REMARK   3   MEAN B VALUE      (OVERALL, A**2) : 26.1
REMARK   3   OVERALL ANISOTROPIC B VALUE.
REMARK   3    B11 (A**2) : NULL
REMARK   3    B22 (A**2) : NULL
REMARK   3    B33 (A**2) : NULL
REMARK   3    B12 (A**2) : NULL
REMARK   3    B13 (A**2) : NULL
REMARK   3    B23 (A**2) : NULL
REMARK   3
REMARK   3  ESTIMATED COORDINATE ERROR.
REMARK   3   ESD FROM LUZZATI PLOT        (A) : 0.30
REMARK   3   ESD FROM SIGMAA              (A) : 0.41
REMARK   3   LOW RESOLUTION CUTOFF        (A) : 5.00
REMARK   3
REMARK   3  CROSS-VALIDATED ESTIMATED COORDINATE ERROR.
REMARK   3   ESD FROM C-V LUZZATI PLOT    (A) : 0.44
REMARK   3   ESD FROM C-V SIGMAA          (A) : 0.51
REMARK   3
REMARK   3  RMS DEVIATIONS FROM IDEAL VALUES.
REMARK   3   BOND LENGTHS                 (A) : 0.006
REMARK   3   BOND ANGLES            (DEGREES) : 1.3
REMARK   3   DIHEDRAL ANGLES        (DEGREES) : 26.0
REMARK   3   IMPROPER ANGLES        (DEGREES) : 1.04
REMARK   3
REMARK   3  ISOTROPIC THERMAL MODEL : RESTRAINED
REMARK   3
REMARK   3  ISOTROPIC THERMAL FACTOR RESTRAINTS.    RMS    SIGMA
REMARK   3   MAIN-CHAIN BOND              (A**2) : 1.75  ; 1.50
REMARK   3   MAIN-CHAIN ANGLE             (A**2) : 2.92  ; 2.00
REMARK   3   SIDE-CHAIN BOND              (A**2) : 2.57  ; 2.00
REMARK   3   SIDE-CHAIN ANGLE             (A**2) : 3.83  ; 2.50
REMARK   3
REMARK   3  NCS MODEL : RESTRAINTS
REMARK   3
REMARK   3  NCS RESTRAINTS.                         RMS   SIGMA/WEIGHT
REMARK   3   GROUP  1  POSITIONAL            (A) : 0.04  ; 250
REMARK   3   GROUP  1  B-FACTOR           (A**2) : 0.73  ; 1.00
REMARK   3
REMARK   3  PARAMETER FILE  1  : PARHCSDX.PRO
REMARK   3  PARAMETER FILE  2  : PARAM19.SOL
REMARK   3  TOPOLOGY FILE  1   : TOPHCSDX.PRO
REMARK   3  TOPOLOGY FILE  2   : TOPH19.SOL
REMARK   3
REMARK   3  OTHER REFINEMENT REMARKS: BULK SOLVENT MODEL USED
REMARK   4
REMARK   4 1AKJ COMPLIES WITH FORMAT V. 2.2, 16-DEC-1996
REMARK   6
REMARK   6 RESIDUES 1 FROM THE BETA-2-MICROGLOBULIN SUBUNIT
REMARK   6 (CHAIN ID B) AND 115-120 FOR BOTH CD8 SUBUNITS
REMARK   6 (CHAIN IDS D AND E) DO NOT SHOW ELECTRON DENSITY AND HAVE
REMARK   6 NOT BEEN MODELLED.  THE LOOP COMPRISING RESIDUES E26-E31
REMARK   6 FROM ONE OF THE CD8 SUBUNITS SHOWS POOR ELECTRON DENSITY
REMARK   6 AND HIGH B-FACTORS (> 50 A**2).  THIS REGION SHOWS HOWEVER
REMARK   6 SUFFICIENT DENSITY TO DEFINE THE COURSE OF THE POLYPEPTIDE
REMARK   6 MAIN-CHAIN, BUT THE EXACT MAIN-CHAIN TORSION ANGLES AND
REMARK   6 SIDE-CHAIN POSITIONS ARE NOT WELL DEFINED.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200  EXPERIMENT TYPE                : X-RAY DIFFRACTION
REMARK 200  DATE OF DATA COLLECTION        : 13-FEB-1997
REMARK 200  TEMPERATURE           (KELVIN) : 100
REMARK 200  PH                             : 6.5
REMARK 200  NUMBER OF CRYSTALS USED        : 1
REMARK 200
REMARK 200  SYNCHROTRON              (Y/N) : N
REMARK 200  RADIATION SOURCE               : NULL
REMARK 200  BEAMLINE                       : NULL
REMARK 200  X-RAY GENERATOR MODEL          : RIGAKU RU200
REMARK 200  MONOCHROMATIC OR LAUE    (M/L) : M
REMARK 200  WAVELENGTH OR RANGE        (A) : 1.5418
REMARK 200  MONOCHROMATOR                  : NULL
REMARK 200  OPTICS                         : MIRRORS
REMARK 200
REMARK 200  DETECTOR TYPE                  : 30 CM IMAGE PLATE
REMARK 200  DETECTOR MANUFACTURER          : MARRESEARCH
REMARK 200  INTENSITY-INTEGRATION SOFTWARE : DENZO
REMARK 200  DATA SCALING SOFTWARE          : SCALEPACK
REMARK 200
REMARK 200  NUMBER OF UNIQUE REFLECTIONS   : 21379
REMARK 200  RESOLUTION RANGE HIGH      (A) : 2.65
REMARK 200  RESOLUTION RANGE LOW       (A) : 15.0
REMARK 200  REJECTION CRITERIA  (SIGMA(I)) : NULL
REMARK 200
REMARK 200 OVERALL.
REMARK 200  COMPLETENESS FOR RANGE     (%) : 96.5
REMARK 200  DATA REDUNDANCY                : 3.7
REMARK 200  R MERGE                    (I) : NULL
REMARK 200  R SYM                      (I) : 0.095
REMARK 200  <I/SIGMA(I)> FOR THE DATA SET  : 15.2
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200  HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.65
REMARK 200  HIGHEST RESOLUTION SHELL, RANGE LOW  (A) : 2.71
REMARK 200  COMPLETENESS FOR SHELL     (%) : 96.4
REMARK 200  DATA REDUNDANCY IN SHELL       : 2.5
REMARK 200  R MERGE FOR SHELL          (I) : NULL
REMARK 200  R SYM FOR SHELL            (I) : 0.44
REMARK 200  <I/SIGMA(I)> FOR SHELL         : 2.6
REMARK 200
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR
REMARK 200                                         REPLACEMENT
REMARK 200 SOFTWARE USED: AMORE
REMARK 200 STARTING MODEL: PDB ENTRIES 3HLA, 1CD8
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS   (%): 53.2
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.63
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: PROTEIN WAS CRYSTALLIZED FROM
REMARK 280 12% PEG 20000, 100 MM MES, PH 6.5
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21
REMARK 290
REMARK 290      SYMOP   SYMMETRY
REMARK 290     NNNMMM   OPERATOR
REMARK 290       1555   X,Y,Z
REMARK 290       2555   1/2-X,-Y,1/2+Z
REMARK 290       3555   -X,1/2+Y,1/2-Z
REMARK 290       4555   1/2+X,1/2-Y,-Z
REMARK 290
REMARK 290     WHERE NNN -> OPERATOR NUMBER
REMARK 290           MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290   SMTRY1   1  1.000000  0.000000  0.000000        0.00000
REMARK 290   SMTRY2   1  0.000000  1.000000  0.000000        0.00000
REMARK 290   SMTRY3   1  0.000000  0.000000  1.000000        0.00000
REMARK 290   SMTRY1   2 -1.000000  0.000000  0.000000       35.45094
REMARK 290   SMTRY2   2  0.000000 -1.000000  0.000000        0.00000
REMARK 290   SMTRY3   2  0.000000  0.000000  1.000000       57.99791
REMARK 290   SMTRY1   3 -1.000000  0.000000  0.000000        0.00000
REMARK 290   SMTRY2   3  0.000000  1.000000  0.000000       44.79885
REMARK 290   SMTRY3   3  0.000000  0.000000 -1.000000       57.99791
REMARK 290   SMTRY1   4  1.000000  0.000000  0.000000       35.45094
REMARK 290   SMTRY2   4  0.000000 -1.000000  0.000000       44.79885
REMARK 290   SMTRY3   4  0.000000  0.000000 -1.000000        0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 410
REMARK 410 IMGT/3Dstructure-DB annotations
REMARK 410 (http://www.imgt.org)
REMARK 410
REMARK 410 ligand(s)
REMARK 410 reverse transcriptase (POL) peptide 476-484 (P03366)
REMARK 410 IMGT receptor type
REMARK 410
REMARK 410 IMGT receptor description
REMARK 410 Peptide
REMARK 410 Species
REMARK 410 Human immunodeficiency virus 1
REMARK 410 Chain ID
REMARK 410 1akj_C
REMARK 410
REMARK 410 IMGT protein name
REMARK 410 MH1 HLA-A*0201
REMARK 410 IMGT receptor type
REMARK 410 MH
REMARK 410 IMGT receptor description
REMARK 410 MH1-ALPHA_B2M
REMARK 410 Species
REMARK 410 Homo sapiens (human)
REMARK 410 Chain ID
REMARK 410 1akj_A,1akj_B
REMARK 410
REMARK 410 IMGT protein name
REMARK 410 CD8A_CD8A homodimer
REMARK 410 IMGT receptor type
REMARK 410 RPI
REMARK 410 IMGT receptor description
REMARK 410 1V-LIKE_1V-LIKE
REMARK 410 Species
REMARK 410 Homo sapiens (human)
REMARK 410 Chain ID
REMARK 410 1akj_D,1akj_E
REMARK 410
REMARK 410
REMARK 410 Chain ID                1akj_A (1AKJA)
REMARK 410 IMGT chain description  I-ALPHA
REMARK 410 Chain amino acid sequence
REMARK 410 [                                  G-ALPHA1 (1-90) [D1]
REMARK 410 GSHSMRYFFTSVSRPGRGEPRFIAVGYVDDTQFVRFDSDAASQRMEPRAPWIEQEGPEYWDGETRK
REMARK 410                        ][                                  G-ALPHA
REMARK 410 VKAHSQTHRVDLGTLRGYYNQSEAGSHTVQRMYGCDVGSDWRFLRGYHQYAYDGKDYIALKEDLRS
REMARK 410 2 (91-182) [D2]                                  ][
REMARK 410 WTAADMAAQTTKHKWEAAHVAEQLRAYLEGTCVEWLRRYLENGKETLQRTDAPKTHMTHHAVSDHE
REMARK 410                    C-LIKE (183-274) [D3]
REMARK 410 ATLRCWALSFYPAEITLTWQRDGEDQTQDTELVETRPAGDGTFQKWAAVVVPSGQEQRYTCHVQHE
REMARK 410          ]
REMARK 410 GLPKPLTLRWEP
REMARK 410 G-DOMAIN      IMGT domain description  G-ALPHA1
REMARK 410 G-DOMAIN      IMGT gene and allele     Homo sapiens HLA-A*0201
REMARK 410 G-DOMAIN      IMGT gene and allele     (100%)
REMARK 410 G-DOMAIN      ..........GSHSMRY.FFTSVSRPGRGEPRFIAVGYVDDTQFVRFDSDAA
REMARK 410 G-DOMAIN      SQRMEPRA.......PWIEQEGPEYWDGETRKVKAHSQTHRVDLGTLRGYYN
REMARK 410 G-DOMAIN      QSEA
REMARK 410 G-DOMAIN      IMGT domain description  G-ALPHA2
REMARK 410 G-DOMAIN      IMGT gene and allele     Homo sapiens HLA-A*0201
REMARK 410 G-DOMAIN      IMGT gene and allele     (100%)
REMARK 410 G-DOMAIN      ..........GSHTVQRMYGCDVGSDWRFLRGYHQYAYDGKDYIALKED..L
REMARK 410 G-DOMAIN      RSWTAAD.......MAAQTTKHKWEAA.HVAEQLRAYLEGTCVEWLRRYLEN
REMARK 410 G-DOMAIN      GKETLQRT
REMARK 410 C-LIKE-DOMAIN IMGT domain description  C-LIKE
REMARK 410 C-LIKE-DOMAIN IMGT gene and allele     Homo sapiens HLA-A*0201
REMARK 410 C-LIKE-DOMAIN IMGT gene and allele     (100%)
REMARK 410 C-LIKE-DOMAIN Sheet composition        [A B D E] [C F G]
REMARK 410 C-LIKE-DOMAIN .......DAPKTHMTHHAVSD......HEATLRCWALSFYP..AEITLTWQR
REMARK 410 C-LIKE-DOMAIN DGEDQTQ..DTELVETRPAGD......GTFQKWAAVVVPSG.....QEQRYT
REMARK 410 C-LIKE-DOMAIN CHVQHEG..LPKPLTLRW
REMARK 410
REMARK 410 Chain ID                1akj_B (1AKJB)
REMARK 410 IMGT chain description  B2M
REMARK 410 Chain amino acid sequence
REMARK 410 [                                       C-LIKE (1-98) [D1]
REMARK 410 IQRTPKIQVYSRHPAENGKSNFLNCYVSGFHPSDIEVDLLKNGERIEKVEHSDLSFSKDWSFYLLY
REMARK 410                                 ]
REMARK 410 YTEFTPTEKDEYACRVNHVTLSQPKIVKWDRDM
REMARK 410 C-LIKE-DOMAIN IMGT domain description  C-LIKE
REMARK 410 C-LIKE-DOMAIN IMGT gene and allele     Homo sapiens B2M*01
REMARK 410 C-LIKE-DOMAIN IMGT gene and allele     (100%), Homo sapiens
REMARK 410 C-LIKE-DOMAIN IMGT gene and allele     B2M*02 (100%)
REMARK 410 C-LIKE-DOMAIN Sheet composition        [A B D E] [C F G]
REMARK 410 C-LIKE-DOMAIN .....IQRTPKIQVYSRHPAEN....GKSNFLNCYVSGFHP..SDIEVDLLK
REMARK 410 C-LIKE-DOMAIN NGERIE...KVEHSDLSFSKD......WSFYLLYYTEFTPTE.....KDEYA
REMARK 410 C-LIKE-DOMAIN CRVNHVT..LSQPKIVKWDRDM
REMARK 410
REMARK 410 Chain ID                1akj_D (1AKJD)
REMARK 410 IMGT chain description  1V-LIKE
REMARK 410 Chain amino acid sequence
REMARK 410 [                                              V-LIKE (1-113) [D1]
REMARK 410 SQFRVSPLDRTWNLGETVELKCQVLLSNPTSGCSWLFQPRGAAASPTFLLYLSQNKPKAAEGLDTQ
REMARK 410                                               ]
REMARK 410 RFSGKRLGDTFVLTLSDFRRENEGYYFCSALSNSIMYFSHFVPVFLPAKPTTTP
REMARK 410 V-LIKE-DOMAIN IMGT domain description  V-LIKE
REMARK 410 V-LIKE-DOMAIN IMGT gene and allele     Homo sapiens CD8A*01
REMARK 410 V-LIKE-DOMAIN IMGT gene and allele     (100%), Homo sapiens
REMARK 410 V-LIKE-DOMAIN IMGT gene and allele     CD8A*02 (100%)
REMARK 410 V-LIKE-DOMAIN CDR-IMGT length          [7.2.9]
REMARK 410 V-LIKE-DOMAIN FR-IMGT length           [25.21.39.10]
REMARK 410 V-LIKE-DOMAIN Sheet composition        [A' B D E] [A" C C' C" F G]
REMARK 410 V-LIKE-DOMAIN                           [   CDR1   ]
REMARK 410 V-LIKE-DOMAIN .SQFRVSPLDRTWNLGETVELKCQVLLSNP.....TSGCSWLFQPRGAAASP
REMARK 410 V-LIKE-DOMAIN        [  CDR2  ]
REMARK 410 V-LIKE-DOMAIN TFLLYLSQ........NKPKAAEGLDTQRFSGKRLGDTFVLTLSDFRRENEG
REMARK 410 V-LIKE-DOMAIN     [   CDR3    ]
REMARK 410 V-LIKE-DOMAIN YYFCSALSN....SIMYFSHFVPVFLP
REMARK 410
REMARK 410 Chain ID                1akj_E (1AKJE)
REMARK 410 IMGT chain description  1V-LIKE
REMARK 410 Chain amino acid sequence
REMARK 410 [                                              V-LIKE (1-113) [D1]
REMARK 410 SQFRVSPLDRTWNLGETVELKCQVLLSNPTSGCSWLFQPRGAAASPTFLLYLSQNKPKAAEGLDTQ
REMARK 410                                               ]
REMARK 410 RFSGKRLGDTFVLTLSDFRRENEGYYFCSALSNSIMYFSHFVPVFLPAKPTTTP
REMARK 410 V-LIKE-DOMAIN IMGT domain description  V-LIKE
REMARK 410 V-LIKE-DOMAIN IMGT gene and allele     Homo sapiens CD8A*01
REMARK 410 V-LIKE-DOMAIN IMGT gene and allele     (100%), Homo sapiens
REMARK 410 V-LIKE-DOMAIN IMGT gene and allele     CD8A*02 (100%)
REMARK 410 V-LIKE-DOMAIN CDR-IMGT length          [7.2.9]
REMARK 410 V-LIKE-DOMAIN FR-IMGT length           [25.21.39.10]
REMARK 410 V-LIKE-DOMAIN Sheet composition        [A' B D E] [A" C C' C" F G]
REMARK 410 V-LIKE-DOMAIN                           [   CDR1   ]
REMARK 410 V-LIKE-DOMAIN .SQFRVSPLDRTWNLGETVELKCQVLLSNP.....TSGCSWLFQPRGAAASP
REMARK 410 V-LIKE-DOMAIN        [  CDR2  ]
REMARK 410 V-LIKE-DOMAIN TFLLYLSQ........NKPKAAEGLDTQRFSGKRLGDTFVLTLSDFRRENEG
REMARK 410 V-LIKE-DOMAIN     [   CDR3    ]
REMARK 410 V-LIKE-DOMAIN YYFCSALSN....SIMYFSHFVPVFLP
REMARK 999
REMARK 999 SEQUENCE
REMARK 999 1AKJ  A    SWS     P01892       1 -    24 NOT IN ATOMS LIST
REMARK 999 1AKJ  A    SWS     P01892     301 -   365 NOT IN ATOMS LIST
REMARK 999 1AKJ  B    SWS     P01884       1 -    21 NOT IN ATOMS LIST
REMARK 999 1AKJ  D    SWS     P01732       1 -    21 NOT IN ATOMS LIST
REMARK 999 1AKJ  D    SWS     P01732     136 -   235 NOT IN ATOMS LIST
REMARK 999 1AKJ  E    SWS     P01732       1 -    21 NOT IN ATOMS LIST
REMARK 999 1AKJ  E    SWS     P01732     136 -   235 NOT IN ATOMS LIST
DBREF  1AKJ A    1   276  SWS    P01892   1A02_HUMAN      25    300
DBREF  1AKJ B    2    99  SWS    P01884   B2MG_HUMAN      22    119
DBREF  1AKJ C    1     9  PDB    1AKJ     1AKJ             1      9
DBREF  1AKJ D    1   114  SWS    P01732   CD8A_HUMAN      22    135
DBREF  1AKJ E    1   114  SWS    P01732   CD8A_HUMAN      22    135
SEQRES   1 A  276  GLY SER HIS SER MET ARG TYR PHE PHE THR SER VAL SER
SEQRES   2 A  276  ARG PRO GLY ARG GLY GLU PRO ARG PHE ILE ALA VAL GLY
SEQRES   3 A  276  TYR VAL ASP ASP THR GLN PHE VAL ARG PHE ASP SER ASP
SEQRES   4 A  276  ALA ALA SER GLN ARG MET GLU PRO ARG ALA PRO TRP ILE
SEQRES   5 A  276  GLU GLN GLU GLY PRO GLU TYR TRP ASP GLY GLU THR ARG
SEQRES   6 A  276  LYS VAL LYS ALA HIS SER GLN THR HIS ARG VAL ASP LEU
SEQRES   7 A  276  GLY THR LEU ARG GLY TYR TYR ASN GLN SER GLU ALA GLY
SEQRES   8 A  276  SER HIS THR VAL GLN ARG MET TYR GLY CYS ASP VAL GLY
SEQRES   9 A  276  SER ASP TRP ARG PHE LEU ARG GLY TYR HIS GLN TYR ALA
SEQRES  10 A  276  TYR ASP GLY LYS ASP TYR ILE ALA LEU LYS GLU ASP LEU
SEQRES  11 A  276  ARG SER TRP THR ALA ALA ASP MET ALA ALA GLN THR THR
SEQRES  12 A  276  LYS HIS LYS TRP GLU ALA ALA HIS VAL ALA GLU GLN LEU
SEQRES  13 A  276  ARG ALA TYR LEU GLU GLY THR CYS VAL GLU TRP LEU ARG
SEQRES  14 A  276  ARG TYR LEU GLU ASN GLY LYS GLU THR LEU GLN ARG THR
SEQRES  15 A  276  ASP ALA PRO LYS THR HIS MET THR HIS HIS ALA VAL SER
SEQRES  16 A  276  ASP HIS GLU ALA THR LEU ARG CYS TRP ALA LEU SER PHE
SEQRES  17 A  276  TYR PRO ALA GLU ILE THR LEU THR TRP GLN ARG ASP GLY
SEQRES  18 A  276  GLU ASP GLN THR GLN ASP THR GLU LEU VAL GLU THR ARG
SEQRES  19 A  276  PRO ALA GLY ASP GLY THR PHE GLN LYS TRP ALA ALA VAL
SEQRES  20 A  276  VAL VAL PRO SER GLY GLN GLU GLN ARG TYR THR CYS HIS
SEQRES  21 A  276  VAL GLN HIS GLU GLY LEU PRO LYS PRO LEU THR LEU ARG
SEQRES  22 A  276  TRP GLU PRO
SEQRES   1 B   99  ILE GLN ARG THR PRO LYS ILE GLN VAL TYR SER ARG HIS
SEQRES   2 B   99  PRO ALA GLU ASN GLY LYS SER ASN PHE LEU ASN CYS TYR
SEQRES   3 B   99  VAL SER GLY PHE HIS PRO SER ASP ILE GLU VAL ASP LEU
SEQRES   4 B   99  LEU LYS ASN GLY GLU ARG ILE GLU LYS VAL GLU HIS SER
SEQRES   5 B   99  ASP LEU SER PHE SER LYS ASP TRP SER PHE TYR LEU LEU
SEQRES   6 B   99  TYR TYR THR GLU PHE THR PRO THR GLU LYS ASP GLU TYR
SEQRES   7 B   99  ALA CYS ARG VAL ASN HIS VAL THR LEU SER GLN PRO LYS
SEQRES   8 B   99  ILE VAL LYS TRP ASP ARG ASP MET
SEQRES   1 C    9  ILE LEU LYS GLU PRO VAL HIS GLY VAL
SEQRES   1 D  120  SER GLN PHE ARG VAL SER PRO LEU ASP ARG THR TRP ASN
SEQRES   2 D  120  LEU GLY GLU THR VAL GLU LEU LYS CYS GLN VAL LEU LEU
SEQRES   3 D  120  SER ASN PRO THR SER GLY CYS SER TRP LEU PHE GLN PRO
SEQRES   4 D  120  ARG GLY ALA ALA ALA SER PRO THR PHE LEU LEU TYR LEU
SEQRES   5 D  120  SER GLN ASN LYS PRO LYS ALA ALA GLU GLY LEU ASP THR
SEQRES   6 D  120  GLN ARG PHE SER GLY LYS ARG LEU GLY ASP THR PHE VAL
SEQRES   7 D  120  LEU THR LEU SER ASP PHE ARG ARG GLU ASN GLU GLY TYR
SEQRES   8 D  120  TYR PHE CYS SER ALA LEU SER ASN SER ILE MET TYR PHE
SEQRES   9 D  120  SER HIS PHE VAL PRO VAL PHE LEU PRO ALA LYS PRO THR
SEQRES  10 D  120  THR THR PRO
SEQRES   1 E  120  SER GLN PHE ARG VAL SER PRO LEU ASP ARG THR TRP ASN
SEQRES   2 E  120  LEU GLY GLU THR VAL GLU LEU LYS CYS GLN VAL LEU LEU
SEQRES   3 E  120  SER ASN PRO THR SER GLY CYS SER TRP LEU PHE GLN PRO
SEQRES   4 E  120  ARG GLY ALA ALA ALA SER PRO THR PHE LEU LEU TYR LEU
SEQRES   5 E  120  SER GLN ASN LYS PRO LYS ALA ALA GLU GLY LEU ASP THR
SEQRES   6 E  120  GLN ARG PHE SER GLY LYS ARG LEU GLY ASP THR PHE VAL
SEQRES   7 E  120  LEU THR LEU SER ASP PHE ARG ARG GLU ASN GLU GLY TYR
SEQRES   8 E  120  TYR PHE CYS SER ALA LEU SER ASN SER ILE MET TYR PHE
SEQRES   9 E  120  SER HIS PHE VAL PRO VAL PHE LEU PRO ALA LYS PRO THR
SEQRES  10 E  120  THR THR PRO
FORMUL   6  HOH   *108(H2 O1)
HELIX    1   1 PRO A   50  GLU A   53  1                                   4
HELIX    2   2 PRO A   57  TYR A   84  1                                  28
HELIX    3   3 ALA A 1051  ALA A 1061  1                                  11
HELIX    4   4 VAL A 1063  GLU A 1072  1                                  10
HELIX    5   5 THR A 1073  ASN A 1084  1                                  12
HELIX    6   6 LYS A 1086  LEU A 1089  1                                   4
HELIX    7   7 GLU A 2099  ARG A 2101  5                                   3
HELIX    8   8 ARG D   96  ASN D   98  5                                   3
HELIX    9   9 ARG E   96  ASN E   98  5                                   3
SHEET    1   A 6 THR A  31  ASP A  37  0
SHEET    2   A 6 ARG A  21  VAL A  28 -1  N  VAL A  28   O  THR A  31
SHEET    3   A 6 HIS A   3  VAL A  12 -1  N  VAL A  12   O  ARG A  21
SHEET    4   A 6 THR A1004  VAL A1013 -1  N  VAL A1013   O  HIS A   3
SHEET    5   A 6 PHE A1019  TYR A1028 -1  N  ALA A1027   O  GLN A1006
SHEET    6   A 6 LYS A1031  ALA A1035 -1  N  ILE A1034   O  TYR A1026
SHEET    1   B 3 LYS A2085  PRO A2092  0
SHEET    2   B 3 GLU A2018  LEU A2026 -1  N  ALA A2025   O  LYS A2085
SHEET    3   B 3 LYS A2003  SER A2012 -1  N  SER A2012   O  GLU A2018
SHEET    1   C 3 ILE A2037  ARG A2043  0
SHEET    2   C 3 TYR A2102  HIS A2108 -1  N  GLN A2107   O  THR A2038
SHEET    3   C 3 LEU A2117  ARG A2120 -1  N  LEU A2119   O  CYS A2104
SHEET    1   D 3 LYS B   3  SER B   8  0
SHEET    2   D 3 SER B  18  SER B  26 -1  N  SER B  26   O  LYS B   3
SHEET    3   D 3 LEU B  85  THR B  92 -1  N  PHE B  91   O  ASN B  19
SHEET    1   E 3 ILE B  37  LYS B  43  0
SHEET    2   E 3 TYR B 102  HIS B 108 -1  N  ASN B 107   O  GLU B  38
SHEET    3   E 3 LYS B 117  LYS B 120 -1  N  VAL B 119   O  CYS B 104
SHEET    1   F 4 PHE D   4  SER D   7  0
SHEET    2   F 4 VAL D  19  VAL D  25 -1  N  GLN D  24   O  ARG D   5
SHEET    3   F 4 THR D  86  LEU D  91 -1  N  LEU D  91   O  VAL D  19
SHEET    4   F 4 PHE D  78  LEU D  83 -1  N  LEU D  83   O  THR D  86
SHEET    1   G 4 VAL D 122  VAL D 124  0
SHEET    2   G 4 GLY D 100  ALA D 106 -1  N  TYR D 102   O  VAL D 122
SHEET    3   G 4 CYS D  39  GLN D  44 -1  N  GLN D  44   O  TYR D 101
SHEET    4   G 4 THR D  49  LEU D  54 -1  N  LEU D  54   O  CYS D  39
SHEET    1   H 2 SER D 105  SER D 108  0
SHEET    2   H 2 ILE D 115  PHE D 118 -1  N  TYR D 117   O  ALA D 106
SHEET    1   I 4 PHE E   4  SER E   7  0
SHEET    2   I 4 VAL E  19  VAL E  25 -1  N  GLN E  24   O  ARG E   5
SHEET    3   I 4 THR E  86  LEU E  91 -1  N  LEU E  91   O  VAL E  19
SHEET    4   I 4 PHE E  78  LEU E  83 -1  N  LEU E  83   O  THR E  86
SHEET    1   J 4 VAL E 122  VAL E 124  0
SHEET    2   J 4 GLY E 100  SER E 105 -1  N  TYR E 102   O  VAL E 122
SHEET    3   J 4 CYS E  39  GLN E  44 -1  N  GLN E  44   O  TYR E 101
SHEET    4   J 4 THR E  49  LEU E  54 -1  N  LEU E  54   O  CYS E  39
SHEET    1   K 2 SER E 105  SER E 108  0
SHEET    2   K 2 ILE E 115  PHE E 118 -1  N  TYR E 117   O  ALA E 106
SSBOND   1 CYS A 1011    CYS A 1074
SSBOND   2 CYS A 2023    CYS A 2104
SSBOND   3 CYS B   23    CYS B  104
SSBOND   4 CYS D   23    CYS D  104
SSBOND   5 CYS E   23    CYS E  104
CISPEP   1 TYR A 2029    PRO A 2030          0         0.17
CISPEP   2 HIS B   29    PRO B   30          0        -0.37
CISPEP   3 GLU C    4    PRO C    5          0        -0.27
CISPEP   4 SER D    7    PRO D    8          0        -0.51
CISPEP   5 SER E    7    PRO E    8          0        -0.11
CRYST1   70.900   89.600  116.000  90.00  90.00  90.00 P 21 21 21    4
ORIGX1      1.000000  0.000000  0.000000        0.00000
ORIGX2      0.000000  1.000000  0.000000        0.00000
ORIGX3      0.000000  0.000000  1.000000        0.00000
SCALE1      0.014104  0.000000  0.000000        0.00000
SCALE2      0.000000  0.011161  0.000000        0.00000
SCALE3      0.000000  0.000000  0.008621        0.00000